Company Filing History:
Years Active: 2015
Title: Innovator Spotlight: Angéla Pandur
Introduction
Angéla Pandur, an accomplished inventor based in Mende, Hungary, has made significant contributions to the field of pharmaceuticals. With a focus on innovative processes for drug development, Angéla has secured a patent that showcases his expertise and commitment to advancing medical sciences.
Latest Patents
Angéla holds a patent for a process designed to prepare pharmaceutical compounds and intermediate compounds. His notable invention is a method for synthesizing 2-acetoxi-5-(2-fluor-α-cyclopropyl-carbonyl-benzyl)-4,5,6,7-tetrahydro-4H-thieno[3,2-c]pyridine, commonly known as prasugrel. The process initiates from a crystalline precursor, 5-trityl-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine, and further inventive elements include two novel crystalline forms of this compound, which have potential applications in pharmaceutical preparations.
Career Highlights
Angéla has dedicated his career to pharmaceutical development and innovation. He is currently associated with Egis Pharmaceutical Co., a prominent organization that focuses on developing and manufacturing high-quality medications. His work emphasizes the importance of innovative processes and novel pharmaceutical compounds in enhancing therapeutic options for patients.
Collaborations
Throughout his career, Angéla has collaborated with notable coworkers, including Márta Porcs-Makkay and Balázs Volk. These collaborations reflect a commitment to teamwork in achieving shared goals in the field of pharmaceutical research and development.
Conclusion
In summary, Angéla Pandur stands out as an influential inventor in the pharmaceutical industry. His groundbreaking patent and collaborative efforts underscore his role in the advancement of innovations that aim to improve healthcare outcomes. As he continues his work at Egis Pharmaceutical Co., Angéla represents the spirit of innovation that drives progress in medical science.